Update April 4, 2018
Lower cholesterol levels have not led to a meaningful reduction in deaths from cardiovascular disease. Half of all heart attack victims have normal cholesterol levels, and independent research has shown that inflammation is the real cause of cardiovascular problems. In its natural form, cholesterol is blameless. The system however, continues to push cholesterol lowering drugs called statins, without exploring the real physiological effects of STATIN drugs.
STATIN drugs were designed to interfere with the mevalonate pathway of cholesterol synthesis which inevitably inhibits glial cell cholesterol essential for nerve synapses, (aggressive behaviour, depression, irritability) and ubiquinone which is essential for production of cell energy, and the strength of cell walls. Reduced levels can result in serious side effects such as congestive heart failure, chronic fatigue and inflammation of the liver. In this delicate molecular system statin drugs can also cause muscle pain and short term memory loss.
ALL these elements are vital for proper function of our bodies and our minds
A generous supply is essential for normal nerve function.
Neuromuscular damage often leads to symptoms misdiagnosed as multiple sclerosis, ALS and Parkinson’s disease. We also have to wonder about the growing number of cases of dementia! It’s not all due to age.
Drug companies admit the need to take CoQ10 with statins, but fail to admit it is the statin that in inhibits the production of CoQ20!
Statin drugs have been found to limit the manufacture of brain cholesterol in glial cells resulting in aggressive behavior, irritability, depression and rage. Cholesterol is essential for nerve endings, or synapses, and thus for the proper function of the nervous system.
The brain is dependent upon cholesterol for the formation and function of memory. The increased number of ALS-like cases seen in statin users worldwide was reported by Ralph Edwards in 2007 (Drug Safety 2007;(30(6):515-525) At that time he was Director of the World Health Organization’s VigiBase™ monitoring system in Uppsala Sweden. It can be considered the counterpart of the US Food and Drug Administration’s MedWatch..
Although all this is known by pharmaceutical companies, greater public awareness would affect profits … and we are left to our own devices …
To find the facts and evidence, a starting point is the website of Dr Duane Graveline, www.spacedoc.com, former NASA Astronaut, and USAF Flight Surgeon, whose personal experience with statin drug side effects led him to review research and to publish 3 books, with 4th published by his estate.
LIPITOR Thief of Memory©2002 by Duane Graveline MD
STATIN DRUG SIDE EFFECTS and the Misguided War on Cholesterol © 2004-2006 by Duane Graveline MD
The STATIN DAMAGE CRISIS©2009 by Duane Graveline MD
The Dark Side of Statins Plus the wonders of Cholesterol©2017
by Duane Graveline MD which was published by Spacedoc Media LLC
AFTER Graveline’s death in 2016.
The Cholesterol Myths©2000 by Uffe Ravnskov New Trends Publishing
The Great Cholesterol Con by Malcolm Kendrick MD
Ignore the Awkward: How Cholesterol Myths are Kept Alive©2010 by Uffe Ravnskov MD PhD
You can also search the internet for (drug name) side effects …
The Framingham Heart Study – 67 years of discovery in metabolic disease. 2016 Long MT, Fox CS Rev Endocrinol.
Dr William Castelli, Director of the Framingham Study [the largest continuous study of its kind in the world] states that It has never been proven that saturated fats raise or lower LDL’s. The more saturated fat one ate, the more cholesterol one ate, the more calories one ate, the lower people’s serum cholesterol (LDL). Referenced from 50 Facts on Cholesterol by Pat Dougan http://www.spacedoc.com/articles/
Epidemiological approaches to heart disease: the Framingham Study. 1951 Dawber TR, Meadors GF, Moore FE Jr. Am J Public Health Nations Health. Mar 41(3):279-81.
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J 2009; 157:111-117, Sachdeva A et al.
CHOLESTEROL and the STATIN DRUG NIGHTMARE